Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation

被引:0
|
作者
Shao-Ming Chiu
Kuo-Chin Chang
Tsung-Hui Hu
Chao-Hung Hung
Jing-Houng Wang
Sheng-Nan Lu
Chien-Hung Chen
机构
[1] Kaohsiung Chang Gung Memorial Hospital,Division of Hepatogastroenterology, Department of Internal Medicine
[2] Chang Gung University College of Medicine,undefined
来源
关键词
Hepatitis B virus; Hepatitis B surface antigen; Entecavir; Tenofovir disoproxil fumarate; Tenofovir alafenamide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:665 / 675
页数:10
相关论文
共 50 条
  • [1] Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
    Chiu, Shao-Ming
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Chen, Chien-Hung
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 665 - 675
  • [2] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    [J]. Hepatology International, 2021, 15 : 1328 - 1336
  • [3] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
  • [4] COMPARATIVE EFFICACY AND RENAL SAFETY OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE FOR HBV-INFECTED CANCER PATIENTS UNDERGOING CHEMOTHERAPY
    Lee, I-Cheng
    Lan, Keng-Hsin
    Su, Chien-Wei
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi Hsiang
    [J]. HEPATOLOGY, 2021, 74 : 473A - 474A
  • [5] RENAL AND BONE SAFETY OF TENOFOVIR ALAFENAMIDE VS TENOFOVIR DISOPROXIL FUMARATE
    Post, Frank
    Sax, Paul
    Saag, Michael
    Yin, Michael
    Oka, Shinichi
    Koenig, Ellen
    Trottier, Benoit
    Andrade, Jaime
    Cao, Huyen
    Fordyce, Marshall
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A48 - +
  • [6] Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
    Wang, Fa-Da
    Zhou, Jing
    Li, Lan-Qing
    Li, Yu-Jing
    Wang, Meng -Lan
    Tao, Ya-Chao
    Zhang, Dong-Mei
    Wang, Yong-Hong
    Chen, En-Qiang
    [J]. ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [7] To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide: it's all about choosing the right patient!
    Satsangi, Sandeep
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) : 689 - 690
  • [8] RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR
    Liu, Joanne
    Vutien, Philip
    Huang, Daniel
    Ishigami, Masatoshi
    Daniel, Peter Chen Yang Nikhil
    Ito, Takanori
    Dang, Hansen
    Maeda, Mayumi
    Leong, Jennifer
    Landis, Charles
    Nguyen, Mindie H.
    [J]. HEPATOLOGY, 2021, 74 : 492A - 493A
  • [9] Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
    Hill, A.
    Hughes, S.
    Pozniak, A.
    [J]. HIV MEDICINE, 2018, 19 : S30 - S30
  • [10] Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
    Hill, Andrew
    Hughes, Sophie L.
    Gotham, Dzintars
    Pozniak, Anton L.
    [J]. JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 72 - 79